vs
ADMA BIOLOGICS, INC.（ADMA）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是ADMA BIOLOGICS, INC.的1.6倍（$225.0M vs $139.2M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs 18.4%），ADMA BIOLOGICS, INC.自由现金流更多（$34.6M vs $26.2M），过去两年ADMA BIOLOGICS, INC.的营收复合增速更高（30.4% vs -12.3%）
ADMA生物制剂公司是一家专注于研发、生产及商业化特种血浆来源免疫球蛋白疗法的生物制药企业，主要面向美国市场，为原发性免疫缺陷及其他免疫相关疾病患者、医护人员和医疗机构提供免疫健康领域的治疗方案。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
ADMA vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.6倍
$139.2M
营收增速更快
ROCK
高出6.6%
18.4%
自由现金流更多
ADMA
多$8.3M
$26.2M
两年增速更快
ADMA
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $139.2M | $225.0M |
| 净利润 | $49.4M | — |
| 毛利率 | 63.8% | 25.3% |
| 营业利润率 | 45.1% | 7.9% |
| 净利率 | 35.5% | — |
| 营收同比 | 18.4% | 24.9% |
| 净利润同比 | -55.9% | — |
| 每股收益（稀释后） | $0.20 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADMAROCK
| Q4 25 | $139.2M | $225.0M | ||
| Q3 25 | $134.2M | $310.9M | ||
| Q2 25 | $122.0M | $309.5M | ||
| Q1 25 | $114.8M | $290.0M | ||
| Q4 24 | $117.5M | $180.1M | ||
| Q3 24 | $119.8M | $277.1M | ||
| Q2 24 | $107.2M | $273.6M | ||
| Q1 24 | $81.9M | $292.5M |
净利润ADMAROCK
| Q4 25 | $49.4M | — | ||
| Q3 25 | $36.4M | $-89.1M | ||
| Q2 25 | $34.2M | $26.0M | ||
| Q1 25 | $26.9M | $21.1M | ||
| Q4 24 | $111.9M | — | ||
| Q3 24 | $35.9M | $34.0M | ||
| Q2 24 | $32.1M | $32.2M | ||
| Q1 24 | $17.8M | $24.9M |
毛利率ADMAROCK
| Q4 25 | 63.8% | 25.3% | ||
| Q3 25 | 56.3% | 26.6% | ||
| Q2 25 | 55.1% | 28.4% | ||
| Q1 25 | 53.2% | 26.8% | ||
| Q4 24 | 53.9% | 29.0% | ||
| Q3 24 | 49.8% | 29.4% | ||
| Q2 24 | 53.6% | 30.5% | ||
| Q1 24 | 47.8% | 28.9% |
营业利润率ADMAROCK
| Q4 25 | 45.1% | 7.9% | ||
| Q3 25 | 38.0% | 12.8% | ||
| Q2 25 | 35.1% | 12.8% | ||
| Q1 25 | 30.4% | 8.8% | ||
| Q4 24 | 32.6% | 13.3% | ||
| Q3 24 | 33.1% | 15.6% | ||
| Q2 24 | 36.6% | 14.9% | ||
| Q1 24 | 26.7% | 10.8% |
净利率ADMAROCK
| Q4 25 | 35.5% | — | ||
| Q3 25 | 27.1% | -28.6% | ||
| Q2 25 | 28.1% | 8.4% | ||
| Q1 25 | 23.4% | 7.3% | ||
| Q4 24 | 95.2% | — | ||
| Q3 24 | 30.0% | 12.3% | ||
| Q2 24 | 29.9% | 11.8% | ||
| Q1 24 | 21.7% | 8.5% |
每股收益（稀释后）ADMAROCK
| Q4 25 | $0.20 | — | ||
| Q3 25 | $0.15 | $-2.98 | ||
| Q2 25 | $0.14 | $0.87 | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $0.45 | — | ||
| Q3 24 | $0.15 | $1.11 | ||
| Q2 24 | $0.13 | $1.05 | ||
| Q1 24 | $0.08 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $87.6M | $115.7M |
| 总债务越低越好 | $72.1M | $0 |
| 股东权益账面价值 | $477.3M | $950.4M |
| 总资产 | $624.2M | $1.4B |
| 负债/权益比越低杠杆越低 | 0.15× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ADMAROCK
| Q4 25 | $87.6M | $115.7M | ||
| Q3 25 | $61.4M | $89.4M | ||
| Q2 25 | $90.3M | $43.3M | ||
| Q1 25 | $71.6M | $25.1M | ||
| Q4 24 | $103.1M | $269.5M | ||
| Q3 24 | $86.7M | $228.9M | ||
| Q2 24 | $88.2M | $179.1M | ||
| Q1 24 | $45.3M | $146.7M |
总债务ADMAROCK
| Q4 25 | $72.1M | $0 | ||
| Q3 25 | $72.4M | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | $72.3M | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益ADMAROCK
| Q4 25 | $477.3M | $950.4M | ||
| Q3 25 | $431.2M | $951.8M | ||
| Q2 25 | $398.3M | $1.0B | ||
| Q1 25 | $373.4M | $1.0B | ||
| Q4 24 | $349.0M | $1.0B | ||
| Q3 24 | $231.9M | $1.0B | ||
| Q2 24 | $188.3M | $975.7M | ||
| Q1 24 | $153.7M | $940.2M |
总资产ADMAROCK
| Q4 25 | $624.2M | $1.4B | ||
| Q3 25 | $568.7M | $1.4B | ||
| Q2 25 | $558.4M | $1.5B | ||
| Q1 25 | $510.6M | $1.4B | ||
| Q4 24 | $488.7M | $1.4B | ||
| Q3 24 | $390.6M | $1.4B | ||
| Q2 24 | $376.4M | $1.4B | ||
| Q1 24 | $350.9M | $1.3B |
负债/权益比ADMAROCK
| Q4 25 | 0.15× | 0.00× | ||
| Q3 25 | 0.17× | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | 0.21× | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.6M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $34.6M | $26.2M |
| 自由现金流率自由现金流/营收 | 24.8% | 11.7% |
| 资本支出强度资本支出/营收 | 0.8% | 4.1% |
| 现金转化率经营现金流/净利润 | 0.72× | — |
| 过去12个月自由现金流最近4个季度 | $27.8M | $120.6M |
8季度趋势，按日历期对齐
经营现金流ADMAROCK
| Q4 25 | $35.6M | $35.5M | ||
| Q3 25 | $13.3M | $73.0M | ||
| Q2 25 | $21.1M | $44.9M | ||
| Q1 25 | $-19.7M | $13.7M | ||
| Q4 24 | $50.2M | $19.9M | ||
| Q3 24 | $25.0M | $64.7M | ||
| Q2 24 | $45.6M | $36.5M | ||
| Q1 24 | $-2.2M | $53.2M |
自由现金流ADMAROCK
| Q4 25 | $34.6M | $26.2M | ||
| Q3 25 | $-1.1M | $64.8M | ||
| Q2 25 | $18.7M | $27.3M | ||
| Q1 25 | $-24.4M | $2.3M | ||
| Q4 24 | $47.5M | $14.1M | ||
| Q3 24 | $24.0M | $60.5M | ||
| Q2 24 | $43.6M | $33.5M | ||
| Q1 24 | $-4.6M | $48.8M |
自由现金流率ADMAROCK
| Q4 25 | 24.8% | 11.7% | ||
| Q3 25 | -0.8% | 20.8% | ||
| Q2 25 | 15.3% | 8.8% | ||
| Q1 25 | -21.2% | 0.8% | ||
| Q4 24 | 40.4% | 7.8% | ||
| Q3 24 | 20.0% | 21.8% | ||
| Q2 24 | 40.7% | 12.2% | ||
| Q1 24 | -5.6% | 16.7% |
资本支出强度ADMAROCK
| Q4 25 | 0.8% | 4.1% | ||
| Q3 25 | 10.7% | 2.6% | ||
| Q2 25 | 2.0% | 5.7% | ||
| Q1 25 | 4.1% | 3.9% | ||
| Q4 24 | 2.3% | 3.3% | ||
| Q3 24 | 0.9% | 1.5% | ||
| Q2 24 | 1.9% | 1.1% | ||
| Q1 24 | 2.9% | 1.5% |
现金转化率ADMAROCK
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.62× | 1.73× | ||
| Q1 25 | -0.73× | 0.65× | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | 0.70× | 1.90× | ||
| Q2 24 | 1.42× | 1.13× | ||
| Q1 24 | -0.12× | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADMA
| ADMA Bio Manufacturing Segment | $123.1M | 88% |
| Other | $16.0M | 12% |
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
